ML 120B dihydrochloride

MLN120B dihydrochloride is a potent, orally bioavailable IKKβ inhibitor with a 60 nM IC50, competitively binding ATP. It demonstrates efficacy in suppressing multiple myeloma cell growth in both in vitro and in vivo models, supporting its research utility in oncology and inflammatory diseases like rheumatoid arthritis.